EVOQ logo

Evoq Remedies Ltd

EVOQ·BSE·
₹1.95▲ +0.07 (+3.72%)
Market Cap4.86 Cr
PE Ratio-15.40
Volume28,000
Day High - Low1.97 - 1.93
52W High-Low6.11 - 1.35

Evoq Remedies Ltd (EVOQ): company summary

The company's revenue rose 116.9% annually, but net profit swung from a profit of ₹0 crore to a loss of ₹0 crore.

Evoq Remedies Ltd (EVOQ) is a micro-cap Commercial Services company valued at ₹5 crore operating in Trading & Distributors on the NSE and BSE.

Recent price move
Evoq Remedies Ltd last traded at ₹1.95, up 3.72% on the day.
Financial performance
The company's revenue rose 116.9% annually, but net profit swung from a profit of ₹0 crore to a loss of ₹0 crore. The latest quarter saw revenue drop 100.0% compared to the same quarter a year earlier, and net profit swung from a profit of ₹2 crore to a loss of ₹0 crore.
Valuation multiples
A price-to-earnings ratio is not meaningful here because the company is loss-making; the stock trades at 0.09 times book value.
Things to watch
The company reported a net loss of ₹0 crore in its latest financial year, and the net profit margin fell to -0.9% from 0.3% the prior year. The latest quarter's revenue collapsed 100.0% compared to the same quarter a year earlier, and net profit swung to a loss of ₹0 crore from a profit of ₹2 crore.
Where it stands
EVOQ Remedies Ltd ended its latest financial year with a net loss of ₹0 crore, while revenue grew 116.9% annually. The latest quarter's revenue fell 100.0% compared to the same quarter a year earlier, and net profit swung to a loss of ₹0 crore from a profit of ₹2 crore.

Summarised by DocStoX's model on 2026-10-18 from company filings, exchange data and news. This is a factual summary, not a rating or a recommendation. Informational only, not investment advice. Consult a SEBI-registered adviser before investing.

DocStoX Score
4.1/10
Weak
Fair Value
Sign in to see
ROE
-0.54%
Weak
P/E
-15.40x
Loss-making
Debt / Equity
0.00
Low
Industry
Commercial Services
Trading & Distributors
Overall View
Mixed

Price performance

Day₹1.93
₹1.97
52W₹1.35
₹6.11
DocStoX take

Supported by growth (7.5) and valuation (6.0), but held back by momentum (0.0). Growth looks strong at 7.5, but that is offset by momentum at 0.0 and quality at 1.5. We are calling it Mixed rather than resolving the conflict for you.

DocStoX score

Low confidence
4.1
/10
Weak
Quality
Weak
ROE -0.5%
Valuation
Fair
P/B 0.1× on assets (no earnings to value)
Growth
Strong
Revenue +20.6% 5Y CAGR
Risk
Moderate
D/E 0.00
Momentum
Weak
13% of 52-week range

At a glance

Market Cap
₹5 Cr
52W High / Low
₹6 / ₹1
Dividend Yield
0.00%
Promoter Holding
0.02%
EPS (TTM)
₹-0.10
Book Value
₹17.79

Key highlights

  • Low leverage — D/E 0.00
  • Revenue compounding 21% a year
  • Loss-making — no meaningful P/E
  • Quality is weak (1.5/10)
2 Positives4 Watchouts

Growth

Financials

Shareholding

Technicals

Peers

News

Forecasts

About the company

More data

Filings, corporate actions and ownership detail — opened on demand.

More Commercial Services stocks · Trading & Distributors

Evoq Remedies Ltd peers in Commercial Services

Other Commercial Services stocks on the NSE & BSE. See the full Commercial Services sector list.